Source: International Congress 2019 – Airway diseases and blood cells
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. LeMaster (Los Angeles, United States of America), S. Ingersoll (San Francisco, United States of America), D. Markovic (Los Angeles, United States of America), R. Buhr (Los Angeles, United States of America), M. Flynn (Los Angeles, United States of America), M. Dembek (Los Angeles, United States of America), M. Villareal (Los Angeles, United States of America), R. Mcgill (Los Angeles, United States of America), J. Johnston (San Francisco, United States of America), J. Belperio (Los Angeles, United States of America), C. Cooper (Los Angeles, United States of America), H. Phee (San Francisco, United States of America), I. Barjaktarevic (Los Angeles, United States of America). Comparison of blood and sputum analysis in evaluation of eosinophilic COPD. 2575

Member's Comments

No comment yet.

Related content which might interest you: Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Repeatability of inflammatory analysis in induced sputum samples in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004 Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Clinical analysis of acute exacerbation of COPD cases with increased eosinophilic granulocytes in peripheral blood Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Cytokine profile of blood and sputum at infectional COPD exacerbation Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Cytokine profile of blood and sputum in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006 Evaluation of FeNo measurement as an alternative to sputum eosinophils in a severe asthma population Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Stability of sputum and blood eosinophil levels in COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 Cytokines profile of blood and sputum in COPD exacerbation Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Cytokines profile of blood and sputum in COPD exacerbation Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD Source: Eur Respir J 2016; 47:1562-1564 Year: 2016 Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005 Prediction of imminent COPD exacerbations by sputum analysis Source: Eur Respir J 2003; 22: Suppl. 45, 37s Year: 2003 Applications of induced sputum sampling in asthma and COPD Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Discriminating phenotypes of severe eosinophilic asthma using gene profiling in sputum Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018